Here’s How Much $1000 Invested In Tenet Healthcare 10 Years Ago Would Be Worth Today
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 10 years by 1.22% on an annualized basis.
UBS Upgrades Tenet Healthcare to Buy, Raises Price Target to $111
UBS analyst Andrew Mok upgrades Tenet Healthcare (NYSE:THC) from Neutral to Buy and raises the price target from $83 to $111.
Expert Ratings For Tenet Healthcare
Tenet Healthcare (NYSE:THC) has observed the following analyst ratings within the last quarter:
Credit Suisse Maintains Outperform on Tenet Healthcare, Raises Price Target to $111
Credit Suisse analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $109 to $111.
Deutsche Bank Maintains Buy on Tenet Healthcare, Raises Price Target to $100
Deutsche Bank analyst Pito Chickering maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $80 to $100.
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $99
Barclays analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $87 to $99.
Recap: Tenet Healthcare Q4 Earnings
Tenet Healthcare (NYSE:THC) reported its Q4 earnings results on Monday, February 7, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.